reduce basal insulin dose when starting glp-1 receptor agonist GLP1-RA and SGLT2-i: Implementation and Deescalation Strategies | Cardiovascular Drugs and Therapy Titration algorithm for basal insulin

Light protection Semaglutide degrades when exposed to UV light

Unlike some other GHS peptides, Ipamorelin does not significantly increase appetite (a common side effect of ghrelin receptor activation) at the doses typically used in research protocols

May Protect Against Diabetes In addition to improving heart health and cognitive function, some research suggests that antioxidants could aid in the prevention of type 2 diabetes

This concern may have originated from a 1959 study that first raised the possibility of diuretics affecting glucose metabolism (Freis and Finnerty, 1959) based on the effects of hydrochlorothiazide